"Thymosin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Thymosin. A family of heat-stable, polypeptide hormones secreted by the thymus gland. Their biological activities include lymphocytopoiesis, restoration of immunological competence and enhancement of expression of T-cell characteristics and function. They have therapeutic potential in patients having primary or secondary immunodeficiency diseases, cancer or diseases related to aging.
| Descriptor ID |
D013947
|
| MeSH Number(s) |
D06.472.910.850 D12.644.548.869 D12.776.922
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thymosin".
Below are MeSH descriptors whose meaning is more specific than "Thymosin".
This graph shows the total number of publications written about "Thymosin" by people in this website by year, and whether "Thymosin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Thymosin" by people in Profiles.
-
Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection. Mediators Inflamm. 2021; 2021:9979032.
-
Delayed hospital admission and high-dose corticosteroids potentially prolong SARS-CoV-2 RNA detection duration of patients with COVID-19. Eur J Clin Microbiol Infect Dis. 2021 Apr; 40(4):841-848.
-
Analysis of the prophylactic effect of thymosin drugs on COVID-19 for 435 medical staff: A hospital-based retrospective study. J Med Virol. 2021 03; 93(3):1573-1580.
-
Dysregulated adaptive immune response contributes to severe COVID-19. Cell Res. 2020 09; 30(9):814-816.
-
Possible causes for decreased susceptibility of children to coronavirus. Pediatr Res. 2020 09; 88(3):342.
-
Thymosin ß4: A Multi-Faceted Tissue Repair Stimulating Protein in Heart Injury. Curr Med Chem. 2020; 27(37):6294-6305.
-
Highly effective biosynthesis of N-acetylated human thymosin ß4 (Tß4) in Escherichia coli. Artif Cells Nanomed Biotechnol. 2018; 46(sup3):S95-S104.
-
Thymosin ß4 alleviates renal fibrosis and tubular cell apoptosis through TGF-ß pathway inhibition in UUO rat models. BMC Nephrol. 2017 Oct 18; 18(1):314.
-
Thymosin a1 represents a potential potent single-molecule-based therapy for cystic fibrosis. Nat Med. 2017 May; 23(5):590-600.
-
Thymosin alpha 1 and HIV-1: recent advances and future perspectives. Future Microbiol. 2017 02; 12:141-155.